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Abstract 
Brain glycine receptors as a common target for alcohol and the 
relapse-preventing drug acamprosate – a preclinical study 
PeiPei Chau 
Addiction Biology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience 
and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden 
 
Alcohol abuse and dependence make up the most prevalent categories of substance use 
disorders in the world. Converging evidence from the current research group has 
identified two receptor populations, the glycine (GlyRs) and nicotinic acetylcholine 
receptors (nAChRs) in the mesolimbic dopamine system, as two potentially important 
targets for the development of new medication to treat alcohol dependence. It is 
suggested that ethanol primarily acts via GlyRs in the nucleus accumbens (nAc) with a 
secondary and indirect effect on nAChRs in the ventral tegmental area (VTA), 
subsequently activating dopaminergic neurons leading to an increase of extracellular 
dopamine in the nAc. Pharmacological modulation of these receptors alters the activity 
of the suggested nAc-VTA-nAc circuitry with prominent effects on ethanol-induced 
dopamine elevations as well as ethanol intake. The general aim of this thesis was to 
further investigate the role of these receptors for regulating ethanol-induced dopamine 
and consummatory actions, by using ethanol and substances with possible anti-alcohol 
effects in the rat. Measurements of extracellular dopamine and amino acid levels in the 
nAc were examined using in vivo brain microdialysis in awake, freely-moving male 
Wistar rats. In addition, a voluntary ethanol consumption paradigm with limited access 
was used to measure ethanol intake. The results indicate that the anti-relapse substance 
acamprosate has a similar dopamine-modulating profile as previously observed with 
ethanol and the endogenous GlyR ligand taurine. The acamprosate-induced dopamine 
elevation was demonstrated to be inhibited by pre-treatment with GlyR or nAChR-
antagonists (Paper I). At a behavioral level, the ethanol intake-reducing effect of 
acamprosate was reversed by GlyR antagonism in the nAc (Paper II).  In addition, the 
loss of the ethanol intake-reducing effect of chronic administration of acamprosate is 
potentially linked with its’ dopamine-modulating property (Paper III). The influence of 
acamprosate-related substances, the metabotropic glutamate type 5 receptor (mGluR5) 
antagonist MPEP and taurine, were also investigated. We found that mGluR5 and GlyR 
may have a joint mechanism to activate the dopamine output (Paper IV). Also, an 
augmentation of extracellular taurine levels is required in order to obtain an ethanol-
induced dopamine increase (Paper V). The findings of this thesis have revealed a new 
mechanism of action for the anti-relapse agent acamprosate. But, most importantly, the 
results have further confirmed the relevance of the nAc-VTA-nAc neuronal circuitry for 
alcohol addiction. 
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